Global and United States Drugs for Short Bowel Syndrome Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 GLP-2
  • 1.2.3 Growth Hormone
  • 1.2.4 Glutamine
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Drugs for Short Bowel Syndrome Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2015-2026)
• 2.2 Global Drugs for Short Bowel Syndrome Growth Trends by Regions
  • 2.2.1 Drugs for Short Bowel Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Drugs for Short Bowel Syndrome Historic Market Share by Regions (2015-2020)
  • 2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Drugs for Short Bowel Syndrome Players by Market Size
  • 3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2015-2020)
  • 3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2015-2020)
• 3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
• 3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
  • 3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2019
• 3.5 Key Players Drugs for Short Bowel Syndrome Area Served
• 3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
• 3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Short Bowel Syndrome Breakdown Data by Type (2015-2026)

• 4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2015-2020)
• 4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2021-2026)

5 Drugs for Short Bowel Syndrome Breakdown Data by Application (2015-2026)

• 5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2015-2020)
• 5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Drugs for Short Bowel Syndrome Market Size (2015-2026)
• 6.2 North America Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
• 6.3 North America Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
• 6.4 North America Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Drugs for Short Bowel Syndrome Market Size (2015-2026)
• 7.2 Europe Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
• 7.3 Europe Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
• 7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Drugs for Short Bowel Syndrome Market Size (2015-2026)
• 8.2 China Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
• 8.3 China Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
• 8.4 China Drugs for Short Bowel Syndrome Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Drugs for Short Bowel Syndrome Market Size (2015-2026)
• 9.2 Japan Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
• 9.3 Japan Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
• 9.4 Japan Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Drugs for Short Bowel Syndrome Market Size (2015-2026)
• 10.2 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
• 10.3 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
• 10.4 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Ardelyx
  • 11.1.1 Ardelyx Company Details
  • 11.1.2 Ardelyx Business Overview
  • 11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
  • 11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2015-2020))
  • 11.1.5 Ardelyx Recent Development
• 11.2 Emmaus Life Sciences
  • 11.2.1 Emmaus Life Sciences Company Details
  • 11.2.2 Emmaus Life Sciences Business Overview
  • 11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
  • 11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.2.5 Emmaus Life Sciences Recent Development
• 11.3 GLyPharma Therapeutic
  • 11.3.1 GLyPharma Therapeutic Company Details
  • 11.3.2 GLyPharma Therapeutic Business Overview
  • 11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
  • 11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.3.5 GLyPharma Therapeutic Recent Development
• 11.4 Merck
  • 11.4.1 Merck Company Details
  • 11.4.2 Merck Business Overview
  • 11.4.3 Merck Drugs for Short Bowel Syndrome Introduction
  • 11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.4.5 Merck Recent Development
• 11.5 Naia Pharmaceuticals
  • 11.5.1 Naia Pharmaceuticals Company Details
  • 11.5.2 Naia Pharmaceuticals Business Overview
  • 11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
  • 11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.5.5 Naia Pharmaceuticals Recent Development
• 11.6 Nutrinia
  • 11.6.1 Nutrinia Company Details
  • 11.6.2 Nutrinia Business Overview
  • 11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
  • 11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.6.5 Nutrinia Recent Development
• 11.7 OxThera
  • 11.7.1 OxThera Company Details
  • 11.7.2 OxThera Business Overview
  • 11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
  • 11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.7.5 OxThera Recent Development
• 11.8 Sancilio & Company
  • 11.8.1 Sancilio & Company Company Details
  • 11.8.2 Sancilio & Company Business Overview
  • 11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
  • 11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.8.5 Sancilio & Company Recent Development
• 11.9 Takeda
  • 11.9.1 Takeda Company Details
  • 11.9.2 Takeda Business Overview
  • 11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
  • 11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.9.5 Takeda Recent Development
• 11.10 Zealand Pharma
  • 11.10.1 Zealand Pharma Company Details
  • 11.10.2 Zealand Pharma Business Overview
  • 11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
  • 11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  • 11.10.5 Zealand Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer